|HQ||San Diego, CA, US||Map|
Gross profit (Q1, 2021)
Gross profit margin (Q1, 2021), %
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (26-May-2022)
Closing stock price (26-May-2022)
|Company Name||Date||Deal Size|
|Halozyme Holdings Ltd.|
|Halozyme Switzerland GmbH|
|Halozyme Switzerland Holdings GmbH|
Halozyme Therapeutics revenue breakdown by business segment: 33.1% from Royalties, 46.0% from Revenues under Collaborative Agreements and 20.9% from Product Sales
Halozyme Therapeutics revenue breakdown by geographic segment: 40.0% from United States, 7.5% from Belgium, 35.9% from Switzerland, 11.4% from Ireland and 5.3% from Other
Halozyme Therapeutics has 331 Twitter Followers. The number of followers has increased 3% month over month and increased 8.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Halozyme Therapeutics founded?
Halozyme Therapeutics was founded in 1998.
Who are Halozyme Therapeutics key executives?
Halozyme Therapeutics's key executives are Helen Torley, Mark Snyder and Nicole Labrosse.
How many employees does Halozyme Therapeutics have?
Halozyme Therapeutics has 136 employees.
What is Halozyme Therapeutics revenue?
Latest Halozyme Therapeutics annual revenue is $267.6 m.
What is Halozyme Therapeutics revenue per employee?
Latest Halozyme Therapeutics revenue per employee is $2 m.
Who are Halozyme Therapeutics competitors?
Competitors of Halozyme Therapeutics include Partner Therapeutics, Verastem Oncology and Rakuten Medical.
Where is Halozyme Therapeutics headquarters?
Halozyme Therapeutics headquarters is located at 11388 Sorrento Valley Rd, San Diego.
Where are Halozyme Therapeutics offices?
Halozyme Therapeutics has an office in San Diego.
How many offices does Halozyme Therapeutics have?
Halozyme Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies